| Dr David Wayne French, MD | |
|
403 W Fairview Ave, Eddyville, KY 42038-8259 | |
| (270) 388-5454 | |
| (270) 388-5452 |
| Full Name | Dr David Wayne French |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 33 Years |
| Location | 403 W Fairview Ave, Eddyville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649336306 | NPI | - | NPPES |
| 6429000 | Medicaid | KY | |
| 000000714186 | Other | KY | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 29000 (Kentucky) | Secondary |
| 207Q00000X | Family Medicine | 29000 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Caldwell County Hospital Hha | Princeton, KY | Home health agency |
| Pennyroyal Hospice Inc | Hopkinsville, KY | Hospice |
| Caldwell Medical Center | Princeton, KY | Hospital |
| Baptist Health Madisonville | Madisonville, KY | Hospital |
| Baptist Health Paducah | Paducah, KY | Hospital |
| Princeton Nursing & Rehabilitation | Princeton, KY | Nursing home |
| River's Bend Retirement Community | Kuttawa, KY | Nursing home |
| Christian Care Center Of Kuttawa, Llc | Kuttawa, KY | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Caldwell County Hospital, Inc | 0749275014 | 19 |
News Archive
Most patients younger than age 50 with a torn or severely damaged meniscus experienced reduced pain and improved knee function following transplant surgery, according to a study in the August 5 issue of the Journal of Bone and Joint Surgery. However, many patients required additional surgery within 10 years.
Fears that dead bodies will spread infection and disease following natural disasters are largely baseless, and simply serve to prolong the suffering of surviving friends and family members, according a scientific article published today.
WomanCare Global is pleased to announce an expansion of their global product portfolio to include Roselle, a combined oral contraceptive (COC) pill containing 150 micrograms of levonorgestrel and 30 micrograms of ethinylestradiol and Optinor, a progesterone-only emergency contraception pill (ECP) containing 750 micrograms of levonorgestrel.
VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer whose disease has progressed on or recurred after platinum-based chemotherapy.
› Verified 2 days ago
| Entity Name | Trigg County Hospital, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538218680 PECOS PAC ID: 5193620805 Enrollment ID: O20031205000118 |
News Archive
Most patients younger than age 50 with a torn or severely damaged meniscus experienced reduced pain and improved knee function following transplant surgery, according to a study in the August 5 issue of the Journal of Bone and Joint Surgery. However, many patients required additional surgery within 10 years.
Fears that dead bodies will spread infection and disease following natural disasters are largely baseless, and simply serve to prolong the suffering of surviving friends and family members, according a scientific article published today.
WomanCare Global is pleased to announce an expansion of their global product portfolio to include Roselle, a combined oral contraceptive (COC) pill containing 150 micrograms of levonorgestrel and 30 micrograms of ethinylestradiol and Optinor, a progesterone-only emergency contraception pill (ECP) containing 750 micrograms of levonorgestrel.
VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer whose disease has progressed on or recurred after platinum-based chemotherapy.
› Verified 2 days ago
| Entity Name | Trigg County Hospital, Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1538218680 PECOS PAC ID: 5193620805 Enrollment ID: O20080103000025 |
News Archive
Most patients younger than age 50 with a torn or severely damaged meniscus experienced reduced pain and improved knee function following transplant surgery, according to a study in the August 5 issue of the Journal of Bone and Joint Surgery. However, many patients required additional surgery within 10 years.
Fears that dead bodies will spread infection and disease following natural disasters are largely baseless, and simply serve to prolong the suffering of surviving friends and family members, according a scientific article published today.
WomanCare Global is pleased to announce an expansion of their global product portfolio to include Roselle, a combined oral contraceptive (COC) pill containing 150 micrograms of levonorgestrel and 30 micrograms of ethinylestradiol and Optinor, a progesterone-only emergency contraception pill (ECP) containing 750 micrograms of levonorgestrel.
VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer whose disease has progressed on or recurred after platinum-based chemotherapy.
› Verified 2 days ago
| Entity Name | David W. French, M.d., Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295026466 PECOS PAC ID: 9537345996 Enrollment ID: O20110519000178 |
News Archive
Most patients younger than age 50 with a torn or severely damaged meniscus experienced reduced pain and improved knee function following transplant surgery, according to a study in the August 5 issue of the Journal of Bone and Joint Surgery. However, many patients required additional surgery within 10 years.
Fears that dead bodies will spread infection and disease following natural disasters are largely baseless, and simply serve to prolong the suffering of surviving friends and family members, according a scientific article published today.
WomanCare Global is pleased to announce an expansion of their global product portfolio to include Roselle, a combined oral contraceptive (COC) pill containing 150 micrograms of levonorgestrel and 30 micrograms of ethinylestradiol and Optinor, a progesterone-only emergency contraception pill (ECP) containing 750 micrograms of levonorgestrel.
VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer whose disease has progressed on or recurred after platinum-based chemotherapy.
› Verified 2 days ago
| Entity Name | App Of Kentucky Ed, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497157341 PECOS PAC ID: 0749502862 Enrollment ID: O20141201000389 |
News Archive
Most patients younger than age 50 with a torn or severely damaged meniscus experienced reduced pain and improved knee function following transplant surgery, according to a study in the August 5 issue of the Journal of Bone and Joint Surgery. However, many patients required additional surgery within 10 years.
Fears that dead bodies will spread infection and disease following natural disasters are largely baseless, and simply serve to prolong the suffering of surviving friends and family members, according a scientific article published today.
WomanCare Global is pleased to announce an expansion of their global product portfolio to include Roselle, a combined oral contraceptive (COC) pill containing 150 micrograms of levonorgestrel and 30 micrograms of ethinylestradiol and Optinor, a progesterone-only emergency contraception pill (ECP) containing 750 micrograms of levonorgestrel.
VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer whose disease has progressed on or recurred after platinum-based chemotherapy.
› Verified 2 days ago
| Entity Name | Caldwell County Hospital, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891207460 PECOS PAC ID: 0749275014 Enrollment ID: O20171211001612 |
News Archive
Most patients younger than age 50 with a torn or severely damaged meniscus experienced reduced pain and improved knee function following transplant surgery, according to a study in the August 5 issue of the Journal of Bone and Joint Surgery. However, many patients required additional surgery within 10 years.
Fears that dead bodies will spread infection and disease following natural disasters are largely baseless, and simply serve to prolong the suffering of surviving friends and family members, according a scientific article published today.
WomanCare Global is pleased to announce an expansion of their global product portfolio to include Roselle, a combined oral contraceptive (COC) pill containing 150 micrograms of levonorgestrel and 30 micrograms of ethinylestradiol and Optinor, a progesterone-only emergency contraception pill (ECP) containing 750 micrograms of levonorgestrel.
VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer whose disease has progressed on or recurred after platinum-based chemotherapy.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Wayne French, MD Po Box 595, Eddyville, KY 42038-0595 Ph: (270) 388-5454 | Dr David Wayne French, MD 403 W Fairview Ave, Eddyville, KY 42038-8259 Ph: (270) 388-5454 |
News Archive
Most patients younger than age 50 with a torn or severely damaged meniscus experienced reduced pain and improved knee function following transplant surgery, according to a study in the August 5 issue of the Journal of Bone and Joint Surgery. However, many patients required additional surgery within 10 years.
Fears that dead bodies will spread infection and disease following natural disasters are largely baseless, and simply serve to prolong the suffering of surviving friends and family members, according a scientific article published today.
WomanCare Global is pleased to announce an expansion of their global product portfolio to include Roselle, a combined oral contraceptive (COC) pill containing 150 micrograms of levonorgestrel and 30 micrograms of ethinylestradiol and Optinor, a progesterone-only emergency contraception pill (ECP) containing 750 micrograms of levonorgestrel.
VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer whose disease has progressed on or recurred after platinum-based chemotherapy.
› Verified 2 days ago
Jeremy Webb, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 627 W Fairview Ave, Eddyville, KY 42038 Phone: 270-388-5454 Fax: 270-388-5452 |